Fig. 2From: Impact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional studyInconveniences due to experienced insufficient efficacy of anti-parkinson medication: Data excluding 624 patients with answer as unclear to Hoehn and Yahr stage from stratified analysisBack to article page